Don't like to read?
What if there was a test that could find the reason behind an Illness or disease? This test could possibly save lives and help many people know before it escalates. A research study found that almost 6,600 apparent healthy people that were over the age of 50, would test would predict possible signs of cancer in roughly about 1%. Those who had previously had cancer and the cancer was confirmed in the bloodstream by 38%.
Scientists and experts said that it was a very big and important step to see how the multi-cancer can be detected early before it takes over and how it could fit into the real world of health care. Catherine Marinac is a researcher who works at Dana-Farber Cancer Institute in Boston, and is also a stress co-author, she says that the test might be ahead of its time and not ready for its prime. But she also states that the test could be a total game changer with how useful it is.
A study called Pathfinder which is a study, which was tested at many medical establishments all across the United States. Galleri blood tests are the top number one tests that most doctors trust and use, which are being developed by many various companies. But the main goal is to provide single-step screenings for a variety of cancers.
The Galleri test can test for over 50 different types of tumors, this includes many tumors that might be looked over or are lacking routine checkups, like liver ovarian cancers and pancreatic cancer. Even though this might sound like a miracle, there are issues with cancer screenings, on risk includes a possibility of a false positive that could lead to meddling tests that could not detect any type of cancer.
Marnic believes that it’s important how to detect multi – cancers early and what will happen when they become part of the real world of health care. She also states how the blood test screenings need to be tested properly in order to save lives and take them in for more research so that they may show whether the cancers can be detected by the blood tests which are also way less lethal than other tests.
The Galleri test was made by the California biotech company called GRAIL, which has added funding to the research of the blood testing and Pathfinder study. Other similar tests and the Galleri test are under development with the work being stated on a basic assumption that they will look for biological gestures of any cancer that could possibly be present in the body.
The blood test can also predict where cancer might be located in the body or where there might be a threat to the body, this helps doctors better locate the cancers and decide what decisions could be made and what follow-up tests could be taken as well such as endoscopies, imaging or biopsies which would also be used.
Out of all the patients that they tested that showed up with a positive blood test, over 90% of the patients underwent more than one imaging test, while more than half have had more than one invasive test, there was although many of those were performed on people who did turn out to have cancer, were considered to have a diagnostic journey was longer for people who were in the end and not diagnosed with cancer.
In those cases, doctors were commonly uncertain as to how to stop the diagnostic work-up after the beginning of the tests that showed no cancer. For those patients, the diagnostic intention took an average of 79 days, meaning half had a long wait. Importantly, the scientists found out, when the blood test specify no cancer was present inside the patients and was 99% of the time correct when tested.
Written by Zaylah De La Torre
Edited by Sheena Robertson
Newsmax: Blood Test That Screens for 50 Cancers Found Promising in Preliminary Study
Cancer Network: Blood Test Shows Promise for Detection of Cancer by Silas Inman
Healthline: This New Test Can Detect 50 Types of Cancer from a Single Blood Draw
Featured Image Courtesy of Josh of Flickr – Creative Common License
Inset Image Courtesy of Marco Verch of Flickr – Creative Common License